6-151808084-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000125.4(ESR1):​c.172G>A​(p.Ala58Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,396 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain_significance (no stars). Synonymous variant affecting the same amino acid position (i.e. A58A) has been classified as Benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

ESR1
NM_000125.4 missense

Scores

2
17

Clinical Significance

- - O:1

Conservation

PhyloP100: 2.30

Publications

11 publications found
Variant links:
Genes affected
ESR1 (HGNC:3467): (estrogen receptor 1) This gene encodes an estrogen receptor and ligand-activated transcription factor. The canonical protein contains an N-terminal ligand-independent transactivation domain, a central DNA binding domain, a hinge domain, and a C-terminal ligand-dependent transactivation domain. The protein localizes to the nucleus where it may form either a homodimer or a heterodimer with estrogen receptor 2. The protein encoded by this gene regulates the transcription of many estrogen-inducible genes that play a role in growth, metabolism, sexual development, gestation, and other reproductive functions and is expressed in many non-reproductive tissues. The receptor encoded by this gene plays a key role in breast cancer, endometrial cancer, and osteoporosis. This gene is reported to have dozens of transcript variants due to the use of alternate promoters and alternative splicing, however, the full-length nature of many of these variants remain uncertain. [provided by RefSeq, Jul 2020]
ESR1 Gene-Disease associations (from GenCC):
  • estrogen resistance syndrome
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19596568).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESR1NM_000125.4 linkc.172G>A p.Ala58Thr missense_variant Exon 1 of 8 ENST00000206249.8 NP_000116.2 P03372-1G4XH65

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESR1ENST00000206249.8 linkc.172G>A p.Ala58Thr missense_variant Exon 1 of 8 1 NM_000125.4 ENSP00000206249.3 P03372-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000414
AC:
1
AN:
241670
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
6.85e-7
AC:
1
AN:
1460396
Hom.:
0
Cov.:
37
AF XY:
0.00
AC XY:
0
AN XY:
726506
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33470
American (AMR)
AF:
0.0000224
AC:
1
AN:
44662
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26096
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86140
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111728
Other (OTH)
AF:
0.00
AC:
0
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: -
Submissions summary: Other:1
Revision: -
LINK: link

Submissions by phenotype

Neoplasm Other:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:-
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
19
DANN
Benign
0.96
DEOGEN2
Benign
0.21
T;T;T;T;T;T;T;T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.065
FATHMM_MKL
Benign
0.71
D
LIST_S2
Uncertain
0.92
D;.;.;D;D;.;D;D
M_CAP
Benign
0.033
D
MetaRNN
Benign
0.20
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
.;L;L;.;L;L;.;.
PhyloP100
2.3
PrimateAI
Uncertain
0.68
T
PROVEAN
Benign
1.2
N;N;N;N;N;N;N;N
REVEL
Benign
0.085
Sift
Benign
0.37
T;T;T;T;T;T;T;T
Sift4G
Benign
0.22
T;T;T;T;T;T;T;T
Polyphen
0.0060, 1.0
.;B;B;.;B;B;D;.
Vest4
0.094, 0.093, 0.077, 0.069, 0.10, 0.12
MutPred
0.54
Gain of glycosylation at A58 (P = 0.0173);Gain of glycosylation at A58 (P = 0.0173);Gain of glycosylation at A58 (P = 0.0173);Gain of glycosylation at A58 (P = 0.0173);Gain of glycosylation at A58 (P = 0.0173);Gain of glycosylation at A58 (P = 0.0173);Gain of glycosylation at A58 (P = 0.0173);Gain of glycosylation at A58 (P = 0.0173);
MVP
0.70
MPC
0.50
ClinPred
0.76
D
GERP RS
4.8
PromoterAI
0.013
Neutral
Varity_R
0.10
gMVP
0.43
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1199270277; hg19: chr6-152129219; COSMIC: COSV52785552; COSMIC: COSV52785552; API